• iimveliso-cl1s11

I-SARS-CoV-2 Antigen Assay Kit (Indlela ye-Immunochromatography)

Inkcazelo emfutshane:


  • FOB ixabiso:US $ 0.8 - 1 / Piece
  • Min.Ubungakanani boMyalelo:10000 Iqhekeza / Amaqhekeza
  • Ubunakho bokubonelela:10000000 Iqhekeza/Amaqhekeza ngenyanga
  • :
  • I-Antigen Assay Kit:SARS-CoV-2 Antigen Assay Kit
  • :
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    SARS-CoV-2 Antigen Assay Kit

    (Immunochromatography Method) Product Manual

    PI-RODUCT NAMESARS-CoV-2 Antigen Assay Kit(Indlela ye-Immunochromatography)

    PACKAGING SPECIFICATIONS1 Uvavanyo / Ikhithi

    ABSIPHEPHA

    Inoveli coronaviruses yeyodidi lwe-β. I-COVID-19 sisifo esosulelayo esinamandla sokuphefumla. Ngokuqhelekileyo abantu basengozini. Okwangoku, izigulana ezosulelwe yinoveli coronavirus ngoyena mthombo wosulelo; abantu abosulelekileyo abangenazimpawu nabo banokuba ngumthombo wosulelo. Ngokusekelwe kuphando lwangoku lwe-epidemiological, ixesha lokufukamela yi-1 ukuya kwiintsuku ze-14, ubukhulu becala iintsuku ezi-3 ukuya kwezi-7. Iimpawu eziphambili ziquka umkhuhlane, ukukhathala kunye nokukhwehlela okomileyo. Ukuxinana kweempumlo, impumlo evuzayo, umqala obuhlungu, i-myalgia kunye ne-diarrhea zifumaneka kwiimeko ezimbalwa.

    EXPECTED USAGE

    Le khithi isetyenziselwa ukufumanisa ngokusemgangathweni inoveli coronaviruses (SARS-CoV-2) antigen kwiisampulu zamathe omntu kwi-vitro. Ilungele kuphela ukuxilongwa kwe-in vitro yobungcali, kungekhona ukusetyenziswa komntu.

    Le mveliso isetyenziswa kuphela kwiilabhoratri zeklinikhi okanye uvavanyo olukhawulezileyo ngabasebenzi bezonyango. Ayinakusetyenziselwa uvavanyo lwasekhaya.

    Ayinakusetyenziswa njengesiseko soxilongo kunye nokukhutshelwa ngaphandle kwenyumoniya ebangelwa lusulelo lwenoveli ye-coronavirus (SARS-CoV-2). Ayifanelekanga ukuba ihlolwe ngabantu ngokubanzi.

    Iziphumo zovavanyo lwe-positive zifuna uqinisekiso olungaphaya, kwaye iziphumo zovavanyo olubi azikwazi kuthintela ukosuleleka.

    PRINCIPLES OF THE PI-ROCEI-DURE

    Le mveliso ithatha itekhnoloji ye-colloidal yegolide ye-immunochromatography, ukutshiza igolide ye-colloidal ebhalwe SARS-CoV-2 mono-clonal antibody 1 kwi-pad yegolide I-SARS-CoV-2 monoclonal antibody 2 igqunywe kwi-nitrocellulose membrane njengomgca wovavanyo (umgca we-T) kunye nebhokhwe. I-anti-mouse ye-IgG ye-antibody ifakwe njengomgca wokulawula umgangatho (umgca we-C). Xa isixa esifanelekileyo sesampulu esiza kuvavanywa sidityaniswe kwisampulu yomngxuma wekhadi lovavanyo, isampuli iya kuqhubela phambili ecaleni kwekhadi lovavanyo phantsi kwesenzo se-capillary. Ukuba isampulu iqulethe i-antigen ye-SARS-CoV-2, i-antigen iya kuzibophelela ngegolide ye-colloidal ebhalwe SARS-CoV-2 monoclonal antibody 1, kwaye i-immune complex yenze i-complex ene-SARS-CoV-2 monoclonal antibody 2 egqunyiweyo. Umgca we-T, obonisa umgca we-T omfusa-bomvu, obonisa ukuba i-antigen ye-SARS-CoV-2 ilungile. Ukuba umgca wovavanyo T awubonisi umbala kwaye ubonisa iziphumo ezingalunganga, oko kuthetha ukuba isampuli ayinayo i-antigen ye-SARS-CoV-2. Ikhadi lokuvavanya liqulethe umgca wokulawula umgangatho we-C, kungakhathaliseki ukuba kukho umgca wokuvavanya, umgca wokulawula umgangatho obomvu-obomvu kufuneka uvele. Ukuba umgca wokulawula umgangatho we-C awubonakali, kubonisa ukuba umphumo wokuvavanya awuvumelekanga, kwaye le sampuli kufuneka ihlolwe kwakhona.

    MAIN COMPONENTS

    ( 1) Ikhadi lovavanyo.

    (2) Incwadana.

    Qaphela: Amalungu kwiibhetshi ezahlukeneyo zeekhithi akanakusetyenziswa ngokutshintshanayo.

     

     

    Cat. No. YXN-SARS-AT-01
    Package Specifications 1Test/Kit
    Ikhasethi yovavanyo Uvavanyo olu-1* Ipakethi e-1
    Imanyuwali Iqhekeza eli-1

    STORAGE AND EXPIRATION

    Ixesha lokuqinisekisa ziinyanga ezili-18 ukuba le mveliso igcinwe kwindawo eyi-2℃-30℃.

    Imveliso kufuneka isetyenziswe ngaphakathi kwemizuzu eyi-15 emva kokuba isikhwama se-foil sivulwe.Ukugubungela isiciko ngokukhawuleza emva kokuthatha isisombululo sokukhutshwa kwesampuli. Umhla wemveliso kunye nomhla wokuphelelwa kwexesha ziphawulwe kwileyibhile.

    SAMPLE REQUIREMENTS

    1. Isebenza kwi-swabs yempumlo yomqala, i-oral swabs, isampuli yamathe.

    2. Ukuqokelela isampulu:

    ( 1) Ukuqokelela amathe (YXN-SARS-AT-01): Yenza ucoceko lwezandla ngesepha kunye namanzi / i-alcohol-based rub yesandla. Vula isitya. Yenza ingxolo yeKruuua' emqaleni ukususa amathe kumqala onzulu, emva koko utshice amathe (malunga ne-2 ml) kwisikhongozeli. Kuthintele nakuphi na ukungcoliseka kwamathe kumphezulu ongaphandle wesikhongozeli. Ixesha elilelona lifanelekileyo lokuqokelelwa komfanekiso: Emva kokuvuka nangaphambi kokuxukuxa amazinyo, ukutya okanye ukusela.

     

     

    3. Yenza isampuli ngokukhawuleza kunye nesisombululo sokutsalwa kwesampula esinikezelwe kwikiti emva kokuba isampuli iqokelelwe. Ukuba ayinakucutshungulwa ngokukhawuleza, isampuli kufuneka igcinwe kwityhubhu yeplastiki eyomileyo, inzalo kwaye ivalwe ngokungqongqo. Iyakwazi ukugcinwa kwi-2℃ -8 ℃ kwiiyure ze-8, kwaye inokugcinwa ixesha elide kwi -70 ℃.

    4. Iisampulu ezingcoliseke kakhulu ziintsalela zokutya ngomlomo azinakusetyenziselwa uvavanyo lwale mveliso. Iisampulu eziqokelelwe kwi-swabs ebonakala kakhulu okanye i-agglomerated ayikhuthazwa ukuba kuhlolwe le mveliso. Ukuba i-swabs ihlanjululwe ngexabiso elikhulu legazi, ayikhuthazwa ukuba ihlolwe. Akukhuthazwa ukusebenzisa iisampulu ezicutshungulwayo kunye nesisombululo sokutsalwa kwesampulu esingabonelelwanga kule khithi yokuvavanya le mveliso.

    TESTING METHOD

    Nceda ufunde incwadana yemiyalelo ngononophelo phambi kovavanyo. Nceda ubuyisele zonke iirejenti kwiqondo lobushushu begumbi phambi kovavanyo. Uvavanyo kufuneka lwenziwe kwiqondo lokushisa.

    Amanyathelo ovavanyo:

    1.Isampulu yamathe(YXN-SARS-AT-01):

    ( 1) Emva kokuba ikhasethi yovavanyo ibuyele kwiqondo lobushushu begumbi, vula ingxowa yefoyile yealuminiyam kwaye ukhuphe ikhasethi yovavanyo kwaye uyibeke ngokuthe tye kwidesktop.

    (2) Susa incam yekhasethi yovavanyo, ntywilisela intonga yekhasethi yovavanyo ematheni, okanye ubeke intonga yekhasethi yovavanyo ngaphantsi kolwimi imizuzu emi-2.

    (3) Gcina ikhasethi yovavanyo ime nkqo kwaye uyeke ulwelo lwamathe lunyuke lude lufike okanye luhambe phezu komgca C, emva koko ubuyisele isiciko uze ubeke ikhasethi yovavanyo phezu kwedesika.

    (4) Funda iziphumo ezibonisiweyo kwimizuzu eyi-15-30, kwaye iziphumo ezifundwe emva kwemizuzu engama-30 azivumelekanga.

    [INTERPRETATION OF TEST RESULTS

     

     

    ★Zombini umgca wovavanyo (T) kunye nomgca wolawulo (C) zibonisa iibhendi zemibala njengoko umfanekiso ubonisa ngokufanelekileyo, ebonisa ukuba i-antigen ye-SARS-CoV-2 ilungile.
    ★ OKUNGABIYO: Ukuba kuphela umgca wokulawula umgangatho we-C uphuhlisa umbala kwaye umgca wokuvavanya (T) awuphuhlisi umbala, i-antigen ye-SARSCoV-2 ayibonakali kwaye isiphumo sibi, njengoko umfanekiso ubonisa ngokufanelekileyo.
    ★OKUNGENAKUMBI: Akukho bhanti yombala ibonakala kumgca wokulawula umgangatho (C), kwaye igwetywa njengesiphumo esingasebenziyo nokuba umgca wobhaqo (T) ubonisa ibhendi yombala okanye hayi, njengoko umfanekiso ubonisa njengokulungileyo.Umgca wolawulo uyasilela ukuvela.Umthamo wesampulu engonelanga okanye ubuchule benkqubo obungachanekanga zezona zizathu zinokwenzeka zokungaphumeleli komgca wolawulo.Jonga kwakhona inkqubo kwaye uphinde uvavanyo ngekhasethi entsha yovavanyo.Ukuba ingxaki iyaqhubeka, yeka ukusebenzisa ikiti yovavanyo kwangoko kwaye uqhagamshelane nomthengisi wendawo yakho.

    LIMITATION OF FUMANAION METHOD

    1. Ukuqinisekiswa kweklinikhi

    Ukuze kuvavanywe ukusebenza koxilongo, olu phononongo lusebenzise iisampulu ezine-COVID-19 kubantu abayi-150 kunye ne-COVID-19-abangenayo i-COVID-19 kubantu abangama-350. Le mizekelo yavavanywa kwaye yaqinisekiswa yindlela ye-RT-PCR. Iziphumo zezi zilandelayo:

    a) Uvakalelo :92.67% (139/ 150), 95%CI (87.26%, 96.28%).

    b) Ukuchaza ngokuthe ngqo: 98.29% ( 344/350), 95% CI ( 96.31%, 99.37%).

    2. Ubuncinci bomda wokubona:

    Xa umxholo wentsholongwane ungaphezu kwe-400TCID50 / ml, izinga lokufumanisa okulungileyo likhulu kune-95%. Xa umxholo wentsholongwane ungaphantsi kwe-200TCID50 / ml, izinga lokufumanisa okulungileyo lingaphantsi kwe-95%, ngoko ke umda omncinci wokufumanisa le mveliso ngu-400TCID50 / ml.

    3. Ukuchaneka:

    Iibhetshi ezintathu ezilandelelanayo ze-reagents zavavanywa ngokuchanekileyo. Iibhetshi ezahlukeneyo ze-reagents zisetyenziselwe ukuvavanya isampuli efanayo engalunganga ngamaxesha angama-10 ngokulandelelana, kwaye iziphumo zazingalunganga. Iibhetshi ezahlukeneyo ze-reagents zisetyenziselwe ukuvavanya isampuli elungileyo amaxesha angama-10 ngokulandelelana, kunye

     

     

    zonke iziphumo bezilungile.

    4. I-HOOK isiphumo:

    Xa umxholo wentsholongwane kwisampulu oza kuvavanywa ufikelela kwi-4.0 * 105TCID50 / ml, umphumo wovavanyo awubonakalisi umphumo we-HOOK. 5. Ukuphambana kwentshukumo

    I-Cross-reactivity yeKit iye yavavanywa. Iziphumo zibonise ukuba akukho reactivity emnqamlezweni nalo mzekelo ulandelayo.

     

     

    No Into Conc No Into Conc
    1 HCOV-HKU1 105TCID50/ml 16 Umkhuhlane A H3N2 105TCID50/ml
    2 Staphylococcus aureus 106TCID50/ml 17 H7N9 105TCID50/ml
    3 Iqela A streptococci 106TCID50/ml 18 H5N1 105TCID50/ml
    4 Intsholongwane yemasisi 105TCID50/ml 19 Intsholongwane ka-Epstein-Barr 105TCID50/ml
    5 Intsholongwane kaqwilikana 105TCID50/ml 20 I-Enterovirus CA16 105TCID50/ml
    6 Uhlobo lwe-Adenovirus 3 105TCID50/ml 21 Rhinovirus 105TCID50/ml
    7 Mycoplasmal pneumonia 106TCID50/ml 22 Intsholongwane ebangela usuleleko lwamalungu okuphefumla 105TCID50/ml
    8 Intsholongwane yeParaimfluenza, uhlobo2 105TCID50/ml 23 Streptococcus pneumoniae 106TCID50/ml
    9 I-metapneumovirus yabantu 105TCID50/ml 24 Candida albicans 106TCID50/ml
    10 I-coronavirus yabantu OC43 105TCID50/ml 25 I-Chlamydia pneumoniae 106TCID50/ml
    11 I-coronavirus yabantu 229E 105TCID50/ml 26 Bordetella pertussis 106TCID50/ml
    12 I-Bordetella parapertusis 106TCID50/ml 27 Pneumocystis jiroveci 106TCID50/ml
    13 Umkhuhlane we-B Victoria 105TCID50/ml 28 I-Mycobacterium tubercu ilahleko 106TCID50/ml
    14 Umkhuhlane we-B Y 105TCID50/ml 29 Legionella pneumophila 106TCID50/ml
    15 Umkhuhlane A H1N1 2009 105TCID50/ml

    6. Izinto eziphazamisayo

    Iziphumo zovavanyo aziphazamisi kwi-concentration elandelayo:

     

    No Into Conc No Into Conc
    1 IGazi Elipheleleyo 4% 9 Mucin 0 50%
    2 Ibuprofen 1mg/ml 10 I-Compound Benzoin Gel 1.5mg/ml
    3 tetracycline 3ug/ml 11 Cromolyn glycate 15%
    4 chloramphenicol 3ug/ml 12 I-Deoxyepinephrine hydrochloride 15%
    5 Erythromycin 3ug/ml 13 Afrin 15%
    6 Tobramycin 5% 14 Fluticasone propionate spray 15%
    7 I-Oseltamivir 5mg/ml 15 menthol 15%
    8 Naphazoline Hydrochlor ukukhwela ngeempumlo Drops 15% 16 Mupirocin 10mg/ml

    LIMITATION OF FUMANAION METHOD

    1. Le mveliso inikezelwa kuphela kwiilabhoratri zeklinikhi okanye abasebenzi bezonyango ukuze kuhlolwe ngokukhawuleza, kwaye ayikwazi ukusetyenziselwa uvavanyo lwasekhaya.

    2. Le mveliso ifaneleka kuphela ukufunyanwa kwempumlo yomntu okanye iisampuli zokukhupha umqala. Ibona umxholo wentsholongwane kwisicatshulwa sesampulu, kungakhathaliseki ukuba intsholongwane iyosulela. Ke ngoko, iziphumo zovavanyo lwale mveliso kunye neziphumo zenkcubeko yentsholongwane yesampulu efanayo ayinakunxulumana.

    3. Ikhadi lokuvavanya kunye nesisombululo sokukhutshwa kwesampuli yale mveliso kufuneka ibuyiselwe kwiqondo lokushisa ngaphambi kokusetyenziswa. Ubushushu obungafanelekanga bunokubangela iziphumo zovavanyo olungaqhelekanga.

    4. Ngethuba lenkqubo yokuvavanya, iziphumo zovavanyo zinokuthi zihambelane neziphumo zeklinikhi ngenxa yokungonelanga kwesampuli yokuqokelela i-swabs eyinyumba okanye ukuqokelela okungafanelekanga kunye nokusebenza kwe-specimen extraction.

    5. Ngethuba lokusetyenziswa kwale mveliso, kufuneka ulandele ngokuthe ngqo amanyathelo okusebenza kwencwadana. Amanyathelo okusebenza angafanelekanga kunye neemeko zokusingqongileyo zinokubangela iziphumo zovavanyo ezingaqhelekanga.

    6. I-swab kufuneka ijikelezwe malunga namaxesha angama-10 kudonga lwangaphakathi lombhobho wokuvavanya oqukethe isisombululo sokukhutshwa kwesampuli. Ukujikeleza okumbalwa kakhulu okanye okuninzi kakhulu kunokubangela iziphumo zovavanyo ezingaqhelekanga.

    7. Isiphumo esihle sale mveliso asinakukhupha ithuba lokuba ezinye iintsholongwane zibe zilungile.

    8. Iziphumo zovavanyo olubi ukuba le mveliso ayinakukhuphela ngaphandle amathuba okuba ezinye iipathogens zibe positive.

    9. Iziphumo zovavanyo olubi zicetyiswa ukuba ziqinisekiswe nge-nucleic acid zokufumanisa i-reagents ukuphepha umngcipheko wovavanyo oluphosiweyo.

    10. Kusenokubakho umahluko kwiziphumo zovavanyo phakathi kweisampulu zeklinikhi ezikhenkcezisiweyo kunye neesampulu zeklinikhi ezisanda kuqokelelwa.

    11. Lo mzekelo kufuneka uvavanywe ngoko nangoko emva kokuba uqokelelwe ukuthintela iziphumo zovavanyo ezingaqhelekanga emva kokushiywa ixesha elide kakhulu.

    12. Ngexesha lokusetyenziswa kwale mveliso, isixa sesampulu esifanelekileyo siyimfuneko, isixa sesampulu esincinci okanye esininzi sinokubangela iziphumo zovavanyo ezingaqhelekanga. Kunconywa ukusebenzisa i-pipette kunye nomthamo wesampulu echanekileyo yovavanyo lokudibanisa isampuli.

    PRECAUTIONS

    1. Nceda ulungelelanise isampuli ye-diluent kunye nekhadi lokuvavanya kwiqondo lokushisa kwegumbi (ngaphezu kwe-30min) ngaphambi kokuvavanya.

    2. Ukuhlolwa kufuneka kwenziwe ngokungqinelana nemiyalelo.

    3. Isiphumo kufuneka sitolikwe ngaphakathi kwe-15-30min, kwaye umphumo ofundwe emva kwemizuzu engama-30 awuvumelekanga.

     

     

    4. Isampuli yovavanyo kufuneka ithathwe njengento echaphazelekayo, kwaye umsebenzi kufuneka uqhutywe ngokuhambelana neenkcukacha zokusebenza kwebhubhoratri yesifo esosulelayo, kunye namanyathelo okukhusela kunye nokuqwalaselwa kwi-bio-safety operation.

    5. Le mveliso iqulethe izinto eziphuma kwizilwanyana. Nangona ingosuleli, kufuneka iphathwe ngononophelo xa kusingathwa iindawo ezinokuthi zibe khona zosulelo. Abasebenzisi kufuneka bathathe amanyathelo okhuseleko ukuqinisekisa ukhuseleko lwabo kunye nabanye.

    6. Amakhadi ovavanyo asetyenzisiweyo, iisampuli zesicatshulwa, njl.njl. ziphathwa njengenkunkuma ye-bio-medical emva kovavanyo, kwaye uhlambe izandla zakho ngexesha.

    7. Ukuba isisombululo sonyango lwesampulu sale mveliso sichitheka ngengozi esikhumbeni okanye emehlweni, nceda uhlambe ngokukhawuleza ngamanzi amaninzi, kwaye ufune unyango ukuba kuyimfuneko.

    8. Musa ukusebenzisa ikiti ngomonakalo ocacileyo, kunye nekhadi lokuvavanya kunye nephakheji eyonakele.

    9. Le mveliso yimveliso yokusetyenziswa kwexesha elinye, nceda ungayisebenzisi kwakhona, kwaye ungasebenzisi iimveliso eziphelelwe lixesha.

    10. Gwema ukukhanya kwelanga kunye nokuvuthela ngokuthe ngqo kubalandeli bombane ngexesha lovavanyo.

    11. Amanzi ompompo, amanzi adibeneyo okanye amanzi adibeneyo kunye neziselo azikwazi ukusetyenziswa njengezixhobo zokulawula ezingalunganga.

    12. Ngenxa yokwahlukana kweesampuli, ezinye iilayini zovavanyo zingaba khaphukhaphu okanye zibe ngwevu ngombala. Njengemveliso esemgangathweni, ngokude nje kukho ibhendi kwindawo yomgca we-T, inokugwetywa njengento enhle.

    13. Ukuba uvavanyo lubonisa ukuba unayo, kucetyiswa ukuba usebenzise eli khadi lovavanyo ukuphinda ulitshekishe kube kanye ukuthintela iziganeko ezincinci ezinokwenzeka.

    14. Kukho i-desiccant kwisikhwama se-aluminium foil, ungayithathi ngomlomo






  • Ngaphambili:
  • Okulandelayo:

  • Iimveliso ezinxulumeneyo

    • I-Nucleic Acid Extraction okanye iKhiti yokuCoca

      I-Nucleic Acid Extraction okanye iKhiti yokuCoca

      I-Nucleic Acid Extraction Okanye I-Purification Kit okanye igcinwe ku -20℃. Isampulu kufuneka ithuthwe kusetyenziswa i-0℃ curling. Intshayelelo I-Nucleic Acid Extraction Okanye IKit yokuCoca (iNdlela yeMagnetic Beads) yenzelwe ukucocwa ngokuzenzekelayo kwe-RNA kunye ne-DNA kulwelo lomzimba (olufana ne-swabs, i-plasma, i-serum) kusetyenziswa izixhobo zokutsalwa kwe-nucleic acid ezizenzekelayo. Itekhnoloji ye-Magnetic-particle ibonelela nge-DNA/RNA ekumgangatho ophezulu elungele ...

    • IKhiti entsha yokuFumana iNucleic Acid yeNucleic (SARS-Cov-2).

      Ukuchongwa kwe-Nucleic Acid eNtsha (SARS-Cov-2)...

      INcwadana entsha yeNcwadana yeCoronavirus(SARS-Cov-2) yeNucleic Acid (iNdlela yokuHlola yeFluorescent RT-PCR) 【Igama lemveliso 】I-Coronavirus eNtsha(SARS-Cov-2) iNucleic Acid Detection Kit(Fluorescent RT-PCR Probe Method) 【 iinkcukacha 】 Iimvavanyo ezingama-25/Ikiti 【Usetyenziso olucetywayo】 Le khithi isetyenziselwa ukuchongwa ngokomgangatho we-nucleic acid kwi-coronavirus entsha kwiswabs ye-nasopharyngeal, i-oropharyngeal (umqala) swabs, i-wabs yempumlo yangaphambili, i-swabs ye-turbinate ephakathi, ukuhlamba impumlo kunye ne-aspirates zempumlo ezivela kwi-indivi. ...

    • SARS-CoV-2 Antigen Assay Kit

      SARS-CoV-2 Antigen Assay Kit

      SARS-CoV-2 Antigen Assay Kit (Immunochromatography Method) Incwadi yeMveliso 【IGAMA LEMVELISO】SARS-CoV-2 Antigen Assay Kit (Immunochromatography Indlela) 【IINGCACISO YOKUFAKA】 1 Uvavanyo/IKit 1 ABT/Kit 1 ABT/Kit 1 ABET 】 I ii-coronavirus ezintsha zezodidi lwe-β. I-COVID-19 sisifo esosulelayo esinamandla sokuphefumla. Ngokuqhelekileyo abantu basengozini. Okwangoku, izigulana ezosulelwe yinoveli coronavirus ngoyena mthombo wosulelo; abantu abasulelekileyo abangenazimpawu...

    • Ikhithi yokuFumana i-COVID-19 ye-IgM/IgG ye-Antibody

      Ikhithi yokuFumana i-COVID-19 ye-IgM/IgG ye-Antibody

      I-COVID-19 IgM/IgG yeKhithi yokuFumana i-Antibody ye-COVID-19 (iNdlela ye-Colloidal yeGolide ye-Immunochromatography) Incwadi yeMveliso yeMveliso 【Igama leMveliso】 COVID-19 IgM/IgG Ikhithi yokuFumana i-Antibody ye-Colloidal yeGolide ye-Immunochromatography) 【UVAVANYO UVAVANYO/I-PACKAGING EC EC,I-PACKAGING 1. 【 ISISHWANKATHELO】 Inoveli coronaviruses zezohlobo lwe-β. I-COVID-19 sisifo esosulelayo esinamandla sokuphefumla. Ngokuqhelekileyo abantu basengozini. Okwangoku, abaguli bosulelwe yinoveli coronavirus ngowona mthombo uphambili ...

    Thumela umyalezo wakho kuthi:

    Bhala umyalezo wakho apha kwaye uwuthumele kuthi